Technical Analysis for CTKB - Cytek Biosciences, Inc.

Grade Last Price % Change Price Change
F 6.38 -0.62% -0.04
CTKB closed down 0.62 percent on Tuesday, May 7, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Stochastic Reached Overbought Strength 0.00%
Earnings Movers Other 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.62%
Earnings Movers Other -0.62%
20 DMA Support Bullish 2.57%
Pocket Pivot Bullish Swing Setup 2.57%
Gapped Up Strength 2.57%
Inside Day Range Contraction 2.90%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 17 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 2 % about 21 hours ago
Down 1% about 21 hours ago
60 Minute Opening Range Breakout 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cytek Biosciences, Inc. Description

Cytek Biosciences, Inc. engages in the manufacture and sale of cell analysis solutions for clinical and biomedical research in the fields of drug discovery, genomics, immuno-oncology, immuno-profiling, infectious diseases, inflammatory diseases, and multi-site standardization applications. Its instruments include the Aurora and Northern Lights systems, which are flow cytometers to deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also offers cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. Its customers include pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. Cytek Biosciences, Inc. was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. The company was incorporated in 2014 and is headquartered in Fremont, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biology Laser Infectious Diseases Antibodies Drug Discovery Genomics Cell Biology Inflammatory Diseases Medical Test Blood Test Flow Cytometry Laboratory Techniques Clinical Pathology

Is CTKB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.89
52 Week Low 3.8
Average Volume 768,715
200-Day Moving Average 7.14
50-Day Moving Average 6.67
20-Day Moving Average 6.04
10-Day Moving Average 6.07
Average True Range 0.33
RSI (14) 52.83
ADX 19.87
+DI 22.18
-DI 19.23
Chandelier Exit (Long, 3 ATRs) 6.03
Chandelier Exit (Short, 3 ATRs) 6.48
Upper Bollinger Bands 6.51
Lower Bollinger Band 5.57
Percent B (%b) 0.86
BandWidth 15.52
MACD Line -0.10
MACD Signal Line -0.21
MACD Histogram 0.1085
Fundamentals Value
Market Cap 864.8 Million
Num Shares 136 Million
EPS -0.10
Price-to-Earnings (P/E) Ratio -63.80
Price-to-Sales 6.13
Price-to-Book 2.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.71
Resistance 3 (R3) 6.70 6.57 6.66
Resistance 2 (R2) 6.57 6.49 6.58 6.64
Resistance 1 (R1) 6.48 6.44 6.42 6.49 6.62
Pivot Point 6.35 6.35 6.32 6.36 6.35
Support 1 (S1) 6.26 6.27 6.20 6.27 6.14
Support 2 (S2) 6.13 6.22 6.14 6.12
Support 3 (S3) 6.04 6.13 6.11
Support 4 (S4) 6.05